Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human Neuregulin-3/NRG3 Fc Chimera Protein, CF
Click to view available options
Quantity:
50 μg
Description
Measured by its binding ability in a functional ELISA. Recombinant Human Neuregulin-3/NRG3 Fc Chimera (Catalog # 1373-NR) binds to Recombinant Human ErbB4/Her4 Fc Chimera Protein (Catalog # 1131-ER ) with a ED50 of 15.0-150 ng/mL.
Specifications
Specifications
| Accession Number | P56975.1 |
| For Use With (Application) | Bioactivity |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. |
| Gene ID (Entrez) | 10718 |
| Molecular Weight (g/mol) | M.W. (Observed): 90-100 kDa, under reducing conditions., M.W. (Theroretical): 55 kDa |
| Quantity | 50 μg |
| Source | Human embryonic kidney cell, HEK293-derived human Neuregulin-3/NRG3 protein Human Neuregulin-3/NRG3 (Ser93-Arg359) (N-terminus) Accession # P56975.1 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus) |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| Gene Alias | HRG3, neuregulin 3, neuregulin 3 variant 1, neuregulin 3 variant 10, neuregulin 3 variant 11, neuregulin 3 variant 12, neuregulin 3 variant 13, neuregulin 3 variant 14, neuregulin 3 variant 3, neuregulin 3 variant 4, neuregulin 3 variant 5, neuregulin 3 variant 6, neuregulin 3 variant 7, neuregulin 3 variant 8, neuregulin 3 variant 9, neuregulin-3-like polypeptide, pro-neuregulin-3, membrane-bound isoform, pro-NRG3 |
| Conjugate | Unconjugated |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction